Overview

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Status:
Terminated
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
Safety and Pharmacokinetic study comparing intracisternal EG-1962 to enternal nimopidine in the treatment of aneurysmal subarachnoid hemorrhage.
Phase:
Phase 1
Details
Lead Sponsor:
Edge Therapeutics Inc
Treatments:
Nimodipine